4.5 Article

Documented Adverse Drug Reactions and Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Transplantation

High unmet treatment needs in patients with chronic kidney disease and type 2 diabetes: real-world evidence from a US claims database

Linda Fried et al.

Summary: This study examined the use of antihypertensive and antidiabetic medications in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) in the United States. The study found low initiation and high discontinuation rates of recommended treatments, highlighting the suboptimal adherence to guidelines for halting CKD progression. Patients with comorbidities had higher clinical and economic outcomes, indicating a need for additional treatment options.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Article Urology & Nephrology

Hyperkalemia-Related Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in CKD: A Population-Based Cohort Study

Silvia J. Leon et al.

Summary: Discontinuation of RAAS inhibitors is associated with adverse clinical outcomes in patients with CKD, including high mortality, increased risk of cardiovascular events, and initiation of dialysis.

AMERICAN JOURNAL OF KIDNEY DISEASES (2022)

Article Cardiac & Cardiovascular Systems

Treatment Persistence of Renin-Angiotensin-Aldosterone-System Inhibitors Over Time in Heart Failure with Reduced Ejection Fraction

Muthiah Vaduganathan et al.

Summary: The frequency of early treatment discontinuation is high among heart failure patients, with various factors related to patients and clinicians.

JOURNAL OF CARDIAC FAILURE (2022)

Article Peripheral Vascular Disease

Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use Among Hypertensive US Adults With Albuminuria

Chi D. Chu et al.

Summary: This study observed a slight increase in the prevalence of albuminuria >= 300 mg/g among US adults with hypertension from 2001 to 2018, but no significant changes in the proportion receiving ACE inhibitor/ARB treatment. In the period from 2013 to 2018, the utilization of ACE inhibitor/ARB in adults with diabetes and albuminuria >= 300 mg/g was 55.3%, while it was 33.4% in those without diabetes.

HYPERTENSION (2021)

Article Transplantation

Renin-angiotensin system blocker discontinuation and adverse outcomes in chronic kidney disease

Carl P. Walther et al.

Summary: Discontinuation of ACEI/ARB therapy among patients with non-dialysis-dependent CKD was associated with a higher risk of death and incident ESKD, indicating a need for further investigations into the causes of therapy discontinuation and evidence-based decision-making.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)

Article Medicine, General & Internal

Barriers to ACEI/ARB Use in Proteinuric Chronic Kidney Disease: An Observational Study

Ian E. McCoy et al.

Summary: The study assessed present ACEI and ARB use among patients with proteinuric CKD and found that less than half of patients had active prescriptions on the index date. Barriers such as past AKI, hyperkalemia, advanced CKD, and lack of nephrology care were associated with lower use of ACEIs/ARBs. These barriers may be inappropriate or modifiable in many cases.

MAYO CLINIC PROCEEDINGS (2021)

Article Cardiac & Cardiovascular Systems

Patterns of Use and Clinical Outcomes with Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Heart Failure and Changes in Kidney Function: An Analysis of the Veterans' Health Administrative Database

Roy O. Mathew et al.

Summary: The study revealed that changes in kidney function at admission have a significant impact on the utilization of ACEI/ARB in patients with acute heart failure, and that discharge with ACEI/ARB is associated with lower mortality rates for these patients.

CARDIORENAL MEDICINE (2021)

Article Urology & Nephrology

Development and Validation of a Pragmatic Electronic Phenotype for CKD

Jenna M. Norton et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)

Article Urology & Nephrology

Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD

Sankar D. Navaneethan et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)

Article Public, Environmental & Occupational Health

Are non-allergic drug reactions commonly documented as medication allergies? A national cohort of Veterans' admissions from 2000 to 2014

Kevin W. McConeghy et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)

Editorial Material Urology & Nephrology

KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Management of Blood Pressure in CKD

Sandra J. Taler et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2013)

Article Medicine, General & Internal

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis - A randomized controlled trial

LY Agodoa et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)